ArticleCell death & disease2020

anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells.

Shaochuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.